FDA approves Novo Nordisk fast-acting insulin Fiasp Ruby Khatun Khatun4 Oct 2017 9:57 AM ISTThe U.S. Food and Drug Administration (FDA) on Friday approved Novo Nordisk's fast-acting insulin to treat diabetes.The product, known as Fiasp, is...
Roche Perjeta regimen gets FDA priority review in breast cancer Ruby Khatun Khatun4 Oct 2017 9:20 AM ISTZURICH: The U.S. Food and Drug Administration (FDA) has granted a priority review for Roche's Perjeta in combination with Herceptin and chemotherapy...
DoP directs NPPA to reanalyze price fixation of methylprednisolone Injection 40 mg/ml Ruby Khatun Khatun3 Oct 2017 3:49 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has accepted Sun Pharmaceutical’s review petition against price fixation of “Methylprednisolone...
Lupin gets USFDA nod for infection treating drug Ruby Khatun Khatun3 Oct 2017 10:45 AM ISTNew Delhi: Drug major Lupin said it has received approval from the US health regulator for its doxycycline hyclate tablets used for the treatment of...
Dr Reddys launches Sevelamer Carbonate tablets in US Ruby Khatun Khatun3 Oct 2017 10:01 AM ISTHYDERABAD: Dr. Reddy’s Laboratories Ltd has launched Sevelamer Carbonate tablets, 800 mg, a therapeutic equivalent generic version of Renvela...
Immunotherapy developer Dynavax explores options for Hepatitis B drug - sources Ruby Khatun Khatun3 Oct 2017 9:57 AM ISTDynavax Technologies Corporation, a biotechnology company focused on drugs that harness the immune system to combat disease, is reviewing strategic...
Eli Lilly names new CFO, replaces head of research and development in management shakeup Ruby Khatun Khatun3 Oct 2017 9:35 AM ISTNEW YORK: Eli Lilly and Co named a new chief financial officer and replaced the head of its research and development arm, among other changes to its...
Shire sues Allergan in US over dry eye drug Ruby Khatun Khatun3 Oct 2017 9:15 AM ISTAllergan Plc was sued on Monday by Shire Plc for allegedly scheming to block doctors from prescribing its new treatment for dry eye disease.In a...
Clinical trials in India: Drug Cos to pay 60 percent compensation in 15 days, says Govt Ruby Khatun Khatun2 Oct 2017 11:01 AM ISTNew Delhi: 60% compensation within a 15-day interval has to be paid by drug companies conducting clinical trials in India, in case a patient on whom...
Karnataka cabinet approves biotech policy for 2017-22 Ruby Khatun Khatun2 Oct 2017 10:37 AM ISTNew Delhi: Karnataka Cabinet gave its approval to the state Biotechnology Policy 2017-22 which will give further impetus for the growth of the sector,...
Pfizer Spins Out Biotech Firm With 103 Million dollar In Funding Ruby Khatun Khatun2 Oct 2017 10:29 AM ISTIn keeping with a trend of smaller firms raising buckets of cash using Big Pharma's cast-off drugs, Pfizer Inc. is adapting the strategy for itself by...
Abbott wins US antitrust approval to buy Alere with conditions Ruby Khatun Khatun2 Oct 2017 9:47 AM ISTWASHINGTON: Abbott Laboratories has won U.S. antitrust approval to buy Alere Inc on condition that it sells two point-of-care medical testing...
